Ruud H Brakenhoff

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Squamous Cell Carcinoma

Chronic Kidney Disease

Top Venues

Journal for immunotherapy of cancer

EJNMMI research

This page only lists publications with an associated author ORCID identifier.

Publications

Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Reinout H de Roest, Marijke Stigter van Walsum, Karlijn van der Schilden, Ruud H Brakenhoff
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma. EJNMMI research 14 (1) (2024)
Tara Muijlwijk, Niels E Wondergem, Fatima Ekhlas, Naomi Remkes, Dennis N L M Nijenhuis, Lennart Fritz, Sonja H Ganzevles, Iris H C Miedema, C René Leemans, Jos B Poell, Ruud H Brakenhoff, Rieneke van de Ven
Secretome and immune cell attraction analysis of head and neck cancers. Cancer immunology, immunotherapy : CII 73 (11) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Reinout H de Roest, Marijke Stigter van Walsum, Karlijn van der Schilden, Ruud H Brakenhoff
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma. EJNMMI research 14 (1) (2024)
Anne M van Harten, Ronak Shah, D Vicky de Boer, Marijke Buijze, Maaike Kreft, Ji-Ying Song, Lisa M Zürcher, Heinz Jacobs, Ruud H Brakenhoff
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients. Oncogenesis 13 (1) (2024)
Anne M van Harten, Ronak Shah, D Vicky de Boer, Marijke Buijze, Maaike Kreft, Ji-Ying Song, Lisa M Zürcher, Heinz Jacobs, Ruud H Brakenhoff
Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients. Oncogenesis 13 (1) (2024)
Reinout H de Roest, Marijke Stigter van Walsum, Karlijn van der Schilden, Ruud H Brakenhoff
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma. EJNMMI research 14 (1) (2024)
Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven, Gerben J C Zwezerijnen, Pim de Graaf, K Hakki Karagozoglu, Jan-Jaap Hendrickx, Simone E J Eerenstein, Rolf J Bun, Dorien C Mulder, Jens Voortman, Ronald Boellaard, Albert D Windhorst, J Pascal Hagers, Laura A N Peferoen, Tanja D de Gruijl, Elisabeth Bloemena, Ruud H Brakenhoff, C René Leemans, Catharina Willemien Menke-van der Houven van Oordt
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer. Journal for immunotherapy of cancer 12 (7) (2024)
Jantine E Bakema, Marijke Stigter van Walsum, Jeffrey R Harris, Sonja H Ganzevles, Anantharaman Muthuswamy, Mischa Houtkamp, Theo S Plantinga, Elisabeth Bloemena, Ruud H Brakenhoff, Esther C W Breij, Rieneke van de Ven
An antibody-drug conjugate directed to tissue factor shows preclinical anti-tumor activity in head and neck cancer as a single agent and in combination with chemoradiotherapy. Molecular cancer therapeutics (2023)
Ilkay Evren, Ahmad M Najim, Jos B Poell, Elisabeth R Brouns, Leon J Wils, Laura A N Peferoen, Ruud H Brakenhoff, Elisabeth Bloemena, Erik H van der Meij, Jan G A M de Visscher
The value of regular follow-up of oral leukoplakia for early detection of malignant transformation. Oral diseases (2023)
Leon J Wils, Jos B Poell, Arjen Brink, Ilkay Evren, Elisabeth R Brouns, Jan G A M de Visscher, Elisabeth Bloemena, Ruud H Brakenhoff
Elucidating the genetic landscape of oral leukoplakia to predict malignant transformation. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Ilkay Evren, Elisabeth R Brouns, Jos B Poell, Leon J Wils, Ruud H Brakenhoff, Elisabeth Bloemena, Jan G A M de Visscher
Associations between clinical and histopathological characteristics in oral leukoplakia. Oral diseases (2021)
Irene H Nauta, Daniëlle A M Heideman, Arjen Brink, Berdine van der Steen, Elisabeth Bloemena, Senada Koljenović, Robert J Baatenburg de Jong, C René Leemans, Ruud H Brakenhoff
The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma. International journal of cancer 149 (2) (2021)